Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
2019-07-15 $0.0510 $0.0569 $0.0510 $0.0540 16 484
2019-07-12 $0.0540 $0.0570 $0.0501 $0.0564 60 758
2019-07-11 $0.0577 $0.0637 $0.0479 $0.0540 187 253
2019-07-10 $0.0506 $0.0648 $0.0506 $0.0637 6 719
2019-07-09 $0.0506 $0.0637 $0.0505 $0.0637 6 440
2019-07-08 $0.0625 $0.0625 $0.0625 $0.0625 173
2019-07-05 $0.0590 $0.0648 $0.0520 $0.0625 13 399
2019-07-03 $0.0660 $0.0660 $0.0660 $0.0660 1 109
2019-07-02 $0.0640 $0.0659 $0.0563 $0.0659 35 104
2019-07-01 $0.0548 $0.0650 $0.0548 $0.0631 41 223
2019-06-28 $0.0540 $0.0725 $0.0540 $0.0679 39 562
2019-06-27 $0.0724 $0.0748 $0.0550 $0.0599 99 199
2019-06-26 $0.0650 $0.0700 $0.0650 $0.0654 12 589
2019-06-25 $0.0700 $0.0700 $0.0700 $0.0700 47 200
2019-06-24 $0.0625 $0.0700 $0.0625 $0.0700 6 731
2019-06-21 $0.0700 $0.0700 $0.0650 $0.0700 9 162
2019-06-20 $0.0628 $0.0700 $0.0628 $0.0700 11 821
2019-06-19 $0.0605 $0.0700 $0.0605 $0.0700 19 211
2019-06-18 $0.0760 $0.0760 $0.0601 $0.0690 32 693
2019-06-17 $0.0541 $0.0662 $0.0541 $0.0640 31 776
2019-06-14 $0.0515 $0.0639 $0.0515 $0.0627 10 811
2019-06-13 $0.0550 $0.0639 $0.0550 $0.0595 18 678
2019-06-12 $0.0618 $0.0640 $0.0551 $0.0627 8 222
2019-06-11 $0.0505 $0.0649 $0.0505 $0.0638 9 179
2019-06-10 $0.0501 $0.0644 $0.0501 $0.0644 40 147
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT